Sign in

CIK 0001472012

  • Non-accelerated filer

Immunome Inc.

Sign in to watch
Ticker
IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770694340
Phone
+1 610-321-3700
Business address
18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 10,500 shares at an average $19.45 ($204,260)
  5. 4 Open-market buy Director bought 5,000 shares at $20.70 ($103,500)
  6. 4 Planned sale Chief Scientific Officer sold 9,438 shares at $21.64 ($204,238)
  7. 4 Planned sale Chief Financial Officer sold 65,000 shares at an average $21.92 ($1,424,916)
  8. 4 Gift Chief Scientific Officer gave 6,291 shares (gift)
  9. 4 Open-market buy President and CEO bought 25,450 shares at $19.67 ($500,602)
  10. 4 Open-market sale Director sold 65,000 shares at an average $20.55 ($1,335,626)
  11. 4 Open-market buy Director bought 2,000 shares at an average $21.84 ($43,670)
  12. 4 Open-market buy President and CEO bought 4,729 shares at $21.15 ($100,018)
  13. 4 Planned sale Director sold 383,200 shares at an average $21.74 ($8,330,080)
  14. 4 Gift Chief Scientific Officer gave 3,000 shares (gift)
  15. 4 Open-market buy President and CEO bought 7,278 shares at $20.48 ($149,053)
  16. 4 Open-market buy Chief Technical Officer bought 10,000 shares at $20.49 ($204,900)
  17. 4 Open-market buy President and CEO bought 46,511 shares at $21.50 ($999,987)
  18. 4 Option exercise Chief Scientific Officer acquired 22,000 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 10 · 187 filings